Hydrocodone Bitartrate and Acetaminophen NDC 10702-193

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-193Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0193Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10702-193-01	10702019301	100 TABLET in 1 BOTTLE (10702-193-01)Marketed from Jun 22, 2017
10702-193-03	10702019303	30 TABLET in 1 BOTTLE (10702-193-03)Marketed from Jun 22, 2017
10702-193-10	10702019310	1000 TABLET in 1 BOTTLE (10702-193-10)Marketed from Jun 22, 2017
10702-193-50	10702019350	500 TABLET in 1 BOTTLE (10702-193-50)Marketed from Jun 22, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrocodone Bitartrate and Acetaminophen
Generic name (nonproprietary): hydrocodone bitartrate and acetaminophen
Active ingredients: Hydrocodone bitartrate — 7.5 mg/1Acetaminophen — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: KVK-Tech, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209036
Marketing start: Jun 22, 2017
Listing expires: Dec 31, 2027
DEA schedule: CII
Other FDA classes: Opioid Agonists (Mechanism)
Identifiers: Product ID 10702-193_4a169a07-a8cd-ada4-e063-6394a90ac7d2SPL ID 4a169a07-a8cd-ada4-e063-6394a90ac7d2SPL set ID f1063950-b302-4898-81c2-b1626c9c16efRxCUI 856980, 856987, 856992, 856999, 857002, 857005UNII NO70W886KK, 362O9ITL9D
Pharmacologic class: Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702019301 followed by a unit qualifier and the quantity

Package 10702-0193-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 5, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see WARNINGS ], reserve opioid analgesics, including hydrocodone bitartrate for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209036

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209036
Product	Strength	Form · route	Labeler	Product NDC
Hydrocodone Bitartrate and Acetaminophen	Hydrocodone bitartrate 5 mg/1; Acetaminophen 300 mg/1	TabletOral	KVK-Tech, Inc.	10702-192
Hydrocodone Bitartrate and Acetaminophen	Hydrocodone bitartrate 10 mg/1; Acetaminophen 300 mg/1	TabletOral	KVK-Tech, Inc.	10702-194